%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Catherine Schuster Bruce, Petra Brhlikova, Joseph Heath, Patricia McGettigan
The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011–2018
www.plosmedicine.org
www.plosmedicine.org
endstream
endobj
3 0 obj
<>
endobj
4 0 obj
<>/XObject<>>>
endobj
6 0 obj
[16 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/A 17 0 R>>
endobj
17 0 obj
<>
endobj
7 0 obj
<>stream
x[rVr+5BAQdjIi6XFJ TGdޛy/X`bF%>qAewYIβ"O*㠪7=M0Hr?>g%4Ɋ g^~Epw*7~","K^يwkX&<ۜ~?nweA*}
=q$_S1O"]zGQYlTw./Ӡ, Cu0}Y{^?
>?渞x5U~>at(J
fֳ8moLOm:(>SͧHz nױ\ FCs臩?ұaX~=,ˮqZFYTb.L0pρ?HoZL2x'u_2Q,g$#;&U)/7͡o4(JD#{TWdcp>(SSY!^YEƍJ_XAn^ӆ3ǟļ , #ň.̣$zEP5oWe$\C
߬ @ezeٰ̺^%nhS^o +\2uĕ&k*aJw8ww-ɰƿظ TA^=Cn64#DN,#f~n/ ٧7Ȳ7DAF&d$N,@0ԽDBbVC7.[K$ hޡ9ۮ%Ӡ*|˗;vv4wݪtr MWqʑjAzh'lZKr$[{1Њ|
"F'1,?!ŖH#yٱ.3z*3eK*YA9Ly^әt0`k㘡hZ "|)"z)y-H2 v,T,J颳Jd@
6m[LI)ђO*6cLv
rn
24
,t%BVa1D0ƇvS?Xs@]=|4)DSaA)p>Yy8J}X-#dev27Am* ռ,%(QU,IC
+D<&`Xkt*)Ll: aI*-t{p0X (I 3. \R}s7K-I$s lVZ-"eK=9$l,'i4pyJdjX886㸳I* $3bv}uwghA`oPA>K!- \{PK$&WgUR#K}q'u*ּp|3<^z4~f1O,5#2#gcQr0l,jk>b}cL40zPx)9iV"$k0=+TQs5Z~$p(NIU_gJ&+'>Y!MF mIq0wè>L&ae,D|uP5E2hDxR]
5TʩC^ s4hEZRh,Js^ENUj5R3"pZĶRN8fҷMd1ם jd;[Boϖ*&Ҳ5?R-,vKJD2m,7)y<'!g^}_(-2Ƅ/PAFmQ5J&
'(S'^rV<{+GXa|#L
MO`谆i۲
zݔpkn4v.IrM9se 2:kߴ6ԀS1z¾dHN"E}LoQd(1,Lffom8VhP:mcHhy*Xˣx&\6*"쉩ĽA&,*pY<9x NcM\:$ "Z5YHg;E{TZo!4Fy84O\1D/V4
$F <+&RixJݒ2^i6A95)BHV83SRG
hԈo,.
b-ΘsR=oe %* OjsYGYul]5z$Q>M4JY$@Rsf<ރ9Oǩ1MfR9""V_P8RgFS$DCzwpH-^ΒX 64}rmu6e=β:g$۾SUPo^ԐP-$G+@Xھ-K %P4B+X0(BJQS$" A 6%[iU
~HQ/6%
(H5Os|EBng\RJ%P\hzބ`# bMcF^ȸ=w֭_6k9rKu7Gq_YX\ Ọ
r_rꯀ;6H1Iy?pK7ETMEP(XKZSpq%`@`.V-{5C<:$Yfķ0 UQgPչ^ ƢWZ0Co(%1H
,k"גX8Ke`mIJF@N>vgK)Aj9ich=Ջ7[;?Q]I4 epӪs-1)E?:-9sRh}=̰0$<2&Uu.[\O\r ;@Hi
Fmz!3{:AF<"!ߴDF2Ã);VH[,"!
0bE,CNtg[C\P
&!sᾮ5{oHP:'=^8W'Na۷
LpvǷQDI5NW@7AD_.ć(6}>Z%(Ge~7_S^M
^./F=
y*IeJq(_v.>&#I47ҬKޙEPOЄ`jLQ4ETieawKU
dI:5C>
W§'P3_! \(N:p]?REeW{#"J$&&y軮35A$KY%@Xg7IPG4E,0"E
;{Ѫ%Ń-z*
ppڶ9m>txkvA_UJʫp;ΡV>@^̴c$0"q"ëQPK\Q|:!hȩE'0H[_O1тpPK?6kũKHRs
lP2pc_AeF ,ܢ<&lXe!J[|F hzvl:rA.z~dTmR~u S0Q&- TS]Y)K
yYեIO*e|-ӊv+=&ĤOW43_Oh)ט-b H8nY 0B+'۫붙,c^OΫ
aZ|T(L$(4KhGui#z!k̊?<ݘ17VLMJvFhk`{N"L&(\]XS7U.3ALs|"gk\!B45xe/FN_0^ӝ9sc_S}X>%"$ o?5ugsi>H]Ibܵ3xJZ*{__j@S%TM>ٱ1C"
ռc"ZU:kB4x_n9nCȡ3@gsY+^TLOP~Qu}}k4k_
&SN_;zIKrGsv*kEu;>8cϻ~>2{yڟ5MZv1.Aнi^:++XC3eCbVNH痵gH|Oqq1cC9ŭJguZ۴uADyWz>C~`A?n*1Q "wOzsm6 + Vl)´}T*N_swcpF¡MzqQ@9a6<69ᒂWnT;J[BwvD[
.3=PȆY(sٱ Bɏ昉bGB
/ȨG-kQ0GEB\|@Bn/
6@npLQ&c'Sh~8.2W@eG9$q.vt{02C&&YR*LDkSIcUzuhgc022jlJQ&Ar }GzSiAMmrdĢ/+;G\BÍG?7gMQ#}+uNTI3-,tB}a¨iU"
endstream
endobj
18 0 obj
<>
endobj
19 0 obj
<>/XObject<>>>
endobj
20 0 obj
[22 0 R 23 0 R 24 0 R 25 0 R 26 0 R]
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpmed.1002873.ref001)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpmed.1002873.ref002)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpmed.1002873.ref003)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpmed.1002873.ref004)>>
endobj
26 0 obj
<>/Border[0 0 0]/A 27 0 R>>
endobj
27 0 obj
<>
endobj
21 0 obj
<>stream
xZێ}W%"a7C$`gLHm)Zaqapx]$Y~5Me_O
կfUKY`kVC,us~)u[Łjn8&+anqqh}|hʡ?[[r뻏eC7 ̠{K2xr}XO$g?nP[<_t6dypQ\ HZ,Ą6Ǯ674* Ubk).Rp[\Qleat}/M3 T=p7~!&aSdf:/떮F nbȭ{,
ݶdfjZUMju+?Q|`|&